11:54 AM
Nov 14, 2017
 |  BC Extra  |  Financial News

Alnylam raises $700M in follow-on

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) raised $700 million late Monday through the sale of 5.6 million shares at $125 in a bumped-up follow-on underwritten by Goldman Sachs, JPMorgan, Barclays, Credit Suisse, Piper Jaffray, JMP Securities,...

Read the full 149 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >